pe
pep-05249 v1 CC-BY-SA-4.0

Beta-defensin 11 anticancer peptide

An experimental peptide studied in the lab for its ability to kill or slow cancer cells; not an approved drug.

statusbioassayed targetANTICANCER length54 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.386
avg pLDDT60.7
ranking score0.563
STRUCTURE · PEP-05249 × ANTICANCER
ranking0.563
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence54 aa
1510152025303540455054
DLKHLILKAQLARCYKFG GFCYNSMCPPHTKFIGNC HPDHLHCCINMKELEGST
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.5628482103347778 boltz-2
3-letter notation
Asp-Leu-Lys-His-Leu-Ile-Leu-Lys-Ala-Gln-Leu-Ala-Arg-Cys-Tyr-Lys-Phe-Gly-Gly-Phe-Cys-Tyr-Asn-Ser-Met-Cys-Pro-Pro-His-Thr-Lys-Phe-Ile-Gly-Asn-Cys-His-Pro-Asp-His-Leu-His-Cys-Cys-Ile-Asn-Met-Lys-Glu-Leu-Glu-Gly-Ser-Thr
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Beta-defensin 11 anticancer peptide (pep-05249, v1). PeptideModel. https://peptidemodel.com/card/pep-05249
@peptide{pep05249,
  sequence = {DLKHLILKAQLARCYKFGGFCYNSMCPPHTKFIGNCHPDHLHCCINMKELEGST},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use